HistologiX is a GLP compliant Contract Research Organisation (CRO) specialising in Histology, Immunohistochemistry (IHC) and Digital Pathology services.
Founded in 2005, HistologiX partners with clients to support target identification, through biomarker development, in vivo studies to full clinical trial assessment.
Our team of Scientists focus on delivering high quality results and data to enable our clients to progress their drug development. Our flexible approach enables us to solve our clients biggest problems and deliver results on time.
In 2018, the company was acquired by The Intelligent Tissue Group joining Tissue Solutions to provide a single point of access to tissue procurement and tissue analysis services. The capabilities of both companies help transform tissue into life-saving solutions.